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We illustrate a case involving a 51-year-old man who presented to a tertiary hospital with sepsis secondary to an abscess of the
nasal vestibule and pustular eruptions of the nasal mucosa. Associated cellulitis extended across the face to the eye, and mucosal
thickening of the sinuses was seen on computed tomography. The patient underwent incision and drainage and endoscopic sinus
surgery. Blood cultures and swabs were positive for a gram-negative bacillus, Burkholderia pseudomallei.H eh a dm u l t i p l er i s k
factors including travel to an endemic area. The patient received extended antibiotic therapy in keeping with published national
guidelines.MelioidosisiscausedbyBurkholderiapseudomallei,foundinthesoilinNorthernAustraliaandAsia.Itistransmittedvia
cutaneous or inhaled routes, leading to pneumonia, skin or soft tissue abscesses, and genitourinary infections. Risk factors include
diabetes, chronic lung disease, and alcohol abuse. It can exist as a latent, active, or reactivated infection. A high mortality rate has
been identified in patients with sepsis. Melioidosis is endemic in tropical Northern Australia and northeastern Thailand where it is
the most common cause of severe community-acquired sepsis. There is one other report of melioidosis in the literature involving
orbital cellulitis and sinusitis.
1. Melioidosis of the Nose
1.1.Case. A51-year-oldCaucasianmanpresentedtoatertiary
hospital in Melbourne, Australia, with 7 days of headache,
myalgia, fevers, and sweats. There was cellulitis affecting the
right side face with purulent discharge from a tender right
nostril. He had poorly controlled type 2 diabetes requiring
insulin and chronic hepatitis B. He was a 25-pack-year
smoker, drank >6 standard drinks of alcohol per day, and
occasionallysnortedcocaine.Healsotravelledmultipletimes
to Vietnam and worked as a cabinet maker.
He was septic (temperature 39
∘C ,h e a r tr a t e1 1 0b p ma n d
blood pressure 90/70mmHg) with cellulitis extending from
thenoseacrosstherightcheekanduptotherighteye,includ-
ing a preseptal orbital cellulitis. Visual acuity and eye move-
ments were normal. The right nasal vestibule was tender and
swollen with purulent discharge originating from it and the
nasal septum.
Biochemistry revealed an elevated C-reactive protein of
222.7 (𝑁<5 ) and a normal white cell count of 10.2 × 10
9/L
(𝑁 = 4.0–11.0 × 10
9/L), neutrophils 1.95 × 10
9/L( 𝑁=
2.00–8.00), and lymphocytes 0.53 × 10
9/L( 𝑁 = 1.00–4.00).
Computed tomography (CT) revealed right sinus mucosal
thickening and preseptal tissue swelling overlying the right
orbit extending over the zygoma and the nose, with no
intracranial collection, cavernous sinus thrombosis, orbital
collection, or bony erosion (Figures 1 and 2).
The patient underwent endoscopic sinus surgery. A right
nasal vestibule and septal abscess were identified with boggy,
inflamed nasal mucosa (Figures 3 and 4). Incision and
drainage were performed and necrotic tissue debrided, with
samples sent for histopathology and culture. Septal cartilage
was intact. A right uncinectomy, middle meatal antrostomy
and anterior ethmoidectomy were performed. No pus was
seen in the sinuses.
Bloodculturesandswabsfromthenasalcavityrevealeda
gram-negative bacillus, Burkholderia pseudomallei (sensitive
to ceftazidime, cotrimoxazole, and meropenem). The patient
spent 5 days in intensive care, requiring ionotropes for
ongoingsepsis, and afurther4 days on theward. He received
daily nose toilet, saline sinus rinse, topical nasal deconges-
tants, strict blood sugar control, and initial treatment with2 Case Reports in Otolaryngology
Figure 1: Coronal CT view of sinuses showing right-sided sinusitis
with mucosal thickening of the maxillary sinus and anterior eth-
moids.
Figure 2: Sagittal CT view of sinuses showing thickening of the
mucosa of the anterior right side septum and soft tissue thickening
overlying the right side nose and cheek.
intravenous meropenem. Treatment included a further 8
weeks intravenous ceftazidime 2gqid as a “hospital in the
home” patient, followed by 3 months oral Bactrim DS 2 tabs
b dw i t hf o l i ca c i d5 m gd a i l ya n dd o x y c y c l i n e1 0 0m gb d .
2. Discussion
M e l i o i d o s i si sc a u s e db yBurkholderia pseudomallei,f o u n di n
the soil and water of endemic regions, particularly Asia and
Northern Australia. It is also known as Whitmore’s disease,
named after Captain Alfred Whitmore who in 1911 first iso-
lated the bacteria from an opiate addict in Rangoon, Burma
[1].
The annual incidence in the general northern territory
population is 19.6 cases per 100000 population and increases
with wet weather [2].
Figure3:Coalescingpustulareruptionsinvolvingthenasalmucosa.
Figure 4: Right nasal vestibule and right septal abscess with boggy,
inflamed nasal mucosa.
Transmission of melioidosis is via percutaneous or
inhaled routes. The latter was documented during the Viet-
nam War where American soldiers were reported to have
been infected by the aerosol created by helicopters taking off
from rice paddies [3].
Acutemelioidosishasanincubationperiodrangingfrom
1t o2 1d a y s .A n i m a l - t o - h u m a na n dh u m a n - t o - h u m a nt r a n s -
missionsarerare[4].IsolationofB.pseudomalleifrombodily
fluids of patients remains the gold standard in diagnosis.
The most significant risk factors include diabetes, alcohol
abuse, chronic lung, and chronic renal disease [5]. Infected
diabetics have a mortality rate of up to 15% [5].
Melioidosis can present with acute, chronic, or latent
infection with reactivation. Pneumonia is the most frequent
manifestation, followed by genitourinary infections, skin
infections, bacteraemia without evident focus, septic arthri-
tis, osteomyelitis, and encephalomyelitis [5–8].
Theacutephaseoftherapyformelioidosisinvolvesatleast
14daysofmonotherapywitheitherceftazidime,meropenem,
or imipenem. Doxycycline with or without trimethoprim-
sulfamethoxazole is the mainstay of eradication phase ther-
apy, which lasts at least 3 months [9].
The overall mortality rate for melioidosis is about 14%,
with the mortality from septic shock as high as 86%. 97.4%
o ft h ed e c e a s e dh a v ea tl e a s to n er i s kf a c t o r[ 5].
Our patient was immunosupressed with poorly con-
trolled diabetes, hepatitis B, and alcohol abuse. He was likely
originally infected in Vietnam, an endemic area, and had
presented a year previously with a necrotising pneumonia
diagnosed as melioidosis. However, he failed to comply with
treatment and was lost to followup. Reactivation was likelyCase Reports in Otolaryngology 3
from a pustule or abscess in the nose, leading to extension to
surrounding tissues and sepsis.
Asinglepreviouscaseoforbitalcellulitisandsinusitiswas
describedina42-year-oldpreviouslyhealthygentlemanfrom
Singapore in 1996 [10].
Melioidosis is a significant opportunistic infection with
a high mortality rate in immunocompromised patients. In
an age of international travel, surgeons in Australia need to
consider melioidosis, especially in a returned traveller from
an endemic region.
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